Position in VKTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$98,073,213
-$10,149,963 QoQ
Shares Held
3,013,928
-2.0% QoQ
Ownership
2.60%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 34.78729418884592.ToString("F0")%
Shared 0.ToString("F0")%
None 65.21270581115408.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. VKTX ranks #33 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in VKTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $98,073,213 | 3,013,928 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $108,223,176 | 3,076,270 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $98,001,193 | 3,729,117 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $86,063,889 | 3,247,694 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $75,363,838 | 3,120,656 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $104,367,063 | 2,593,615 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $118,696,432 | 1,874,845 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $50,211,439 | 947,207 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $81,948,422 | 999,371 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $28,159,363 | 1,513,131 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $9,859,847 | 890,682 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $21,413,033 | 1,320,977 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,628,871 | 878,611 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,459,169 | 580,763 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,085,933 | 399,241 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,910,772 | 661,168 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,069,512 | 356,504 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $1,033,356 | 224,643 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,618,598 | 257,739 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,687,058 | 448,591 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $769,353 | 121,637 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $484,624 | 86,079 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,994,652 | 342,724 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,221,401 | 169,404 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $373,852 | 79,883 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||